In the BioHarmony Drug Report Database

"Preview" Icon

Phenelzine

Nardil (phenelzine) is a small molecule pharmaceutical. Phenelzine was first approved as Nardil on 1982-01-01. It is used to treat depressive disorder in the USA. The pharmaceutical is active against amine oxidase [flavin-containing] A and amine oxidase [flavin-containing] B. In addition, it is known to target sodium-dependent dopamine transporter, membrane primary amine oxidase, cytochrome P450 2C8, sodium-dependent serotonin transporter, and sodium-dependent noradrenaline transporter.

 

Trade Name

 

Nardil
 

Common Name

 

phenelzine
 

ChEMBL ID

 

CHEMBL1089
 

Indication

 

depressive disorder
 

Drug Class

 

Image (chem structure or protein)

Phenelzine structure rendering